CS
EUCRU

Clear Street’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Clear Street’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,740
Closed -$28.4K – 1450
2023
Q1 		$28.4K Buy
2,740
+100
+4% +$1.04K ﹤0.01% 288
2022
Q4 		$26K Buy
+2,640
New +$26K ﹤0.01% 294
2022
Q1 		– Sell
-8,980
Closed -$90K – 565
2021
Q4 		$90K Buy
+8,980
New +$90K ﹤0.01% 72